Weight Loss and Obesity Management Market By Product Type (Devices, Drugs), Distribution Channel (Institutional Sales, Retail Sales) & Region - Forecast 2022 - 2028
Market Insights on Weight Loss and Obesity Management covering sales outlook, demand forecast and up-to-date key trends
Weight Loss and Obesity Management Market Outlook (2022-2028)
[276 Pages Report] The global weight loss and obesity management market will account for a net worth of US$ 3.68 Billion in 2022, and is predicted to rise at a CAGR of 5.2% over the forecast period to attain a valuation of US$ 4.99 Billion by 2028.
Attributes
Details
Weight Loss and Obesity Management Market Size (2022)
US$ 3.68 Billion
Sales Forecast (2028)
US$ 4.99 Billion
Global Market Growth Rate (2022 to 2028)
5.2% CAGR
Share of Top 5 Market Players
50%
Weight loss and obesity management accounted for 40.9% share of the global obesity treatment market revenue in 2021.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
How The Market Progressed Till June 2022?
Particulars
Details
H1, 2021
5.17%
H1, 2022 Projected
5.18%
H1, 2022 Outlook
4.78%
BPS Change - H1, 2022 (O) - H1, 2022 (P)
(-) 40 ↓
BPS Change - H1, 2022 (O) - H1, 2021
(-) 39 ↓
H1-2022 outlook period in comparison to H1-2022 projected period showed a negative growth in terms of Basis Point Share by 40 BPS. In H1-2022 when compared with H1-2021, the market growth rate of weight loss and obesity management is expected to fall by 39 basis point share (BPS), as per FMI analysis.
The decline in the BPS values is associated with several product and device recalls due to the adverse effects associated with their use. Moreover, limitations in drug therapies for obesity and weight loss such as frequent obesity relapse, has further contributed to the decline in the BPS values.
However, recent approvals from the FDA for semaglutide injections for weight loss and obesity management will propose a positive outlook towards market growth during the forecasted years.
The market is subject to device regulations, product recalls, licencing requirements, and patient safety guidelines, as per the industry and macroeconomic factors. Key developments in the market include the incorporation of endoluminal techniques to treat obesity. This method is as effective as surgical interventions for the management of weight loss and obesity.
Revenue Analysis Of Weight Loss And Obesity Management From 2013 To 2021 Vs Future Market Outlook For 2022 To 2028
From 2013 to 2021, the global weight loss and obesity management market experienced a CAGR of around 4.8%.
The weight loss and obesity management products market covers various product forms such as devices and drugs that are used for managing or reducing weight in obese and overweight patients. Rising global burden of obesity and overweight is driving the need for preventive care.
Obese people are more likely to develop chronic conditions like diabetes, hypertension, and orthopedic problems. As a result, increased awareness of weight-loss procedures is propelling the market forward. Moreover, people are becoming more health-conscious and embracing meal replacements and exercise regimens in order to keep fit and healthy. This is one of the major reasons driving the weight management market growth.
Other factors driving market expansion include rising disposable incomes and consumer spending power, as well as the emergence of gym culture and an increase in the use of dietary supplements.
The global weight loss and obesity management systems market is anticipated to expand at a 5.2% CAGR from 2022 to 2028.
What Key Factors Are Bolstering Demand For Weight Loss And Obesity Management Products?
“Emergence of New Technologies & Therapies Assisting Market Growth”
New Product Launches for Weight Loss and Obesity Management Continue to Extend Drug Pipeline
Various big pharmaceutical companies are developing novel anti-obesity drugs for weight loss and obesity management. Obesity is now the most investigated indication by the number of clinical trials. The obesity drugs pipeline consists of 94 trials across all stages of clinical development.
Government Initiatives Support Efforts to Tackle Obesity
Government organizations serve numerous vital functions in a national public health crisis, including the childhood obesity epidemic. It provides leadership by responding to prevalent obesity as an urgent public health priority and coordinating the public and private sector response.
Despite government policy responses and greater individual responsibility, global obesity levels look set to keep rising. Government regulations and taxes might increase awareness of weight management and put pressure on food and beverage companies to reduce the calorific value of their products.
Find your sweet spots for generating winning opportunities in this market.
What Challenges Do Weight Loss And Obesity Management Device Suppliers Face?
“Side Effects of Drugs & Other Risks Associated with Weight Loss Surgeries to Obstruct Demand for Surgical Equipment”
It has been proven that bariatric surgery is more effective in terms of cost and treatment than other pharmaceutical interventions for weight loss and obesity management. However, this proven effectiveness is typically associated with certain risks that cannot be understated. Some of the major risks associated are excessive bleeding, infections, blood clots, low blood sugar, and malnutrition.
High cost involved in the R&D of obesity drugs is a great challenge for the growth of the market. Side effects of drugs and risks associated with surgeries may hamper the growth of the global weight loss management market during the forecast period.
Which Region Is Becoming An Attractive Market For Weight Loss And Obesity Management Device Manufacturers?
“Rising Initiatives for Healthy LifestylesDriving Market Growthin North America”
North America is expected to account 43% share of the weight loss and obesity management market in 2022. Major factors boosting the market growth in the region include the rising prevalence of obesity and chronic diseases, favorable government initiatives about nutrition and healthy lifestyles, a growing number of fitness centers, and a rise in disposable income.
Growing awareness about obesity management in the population and the presence of major drug manufacturers are driving the market growth in North America.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Country-Wise Analysis
Why is Demand for Weight Loss and Obesity Management Products Constantly Increasing in the U.S.?
“Rapid Adoption of Weight Loss Management Services to Augment Market Growth”
Rising investments & collaborations in weight loss and obesity management business, rising disposable incomes coupled with changing lifestyles due to rapid urbanization, and commercial availability of liposuction devices are the factors driving market expansion in the U.S.
Increasing incidences of hypertension & diabetes and high adoption of weight loss management services are expected to drive the market growth in the U.S. over the coming years.
How is India Contributing to Weight Loss and Obesity Management Market Growth?
“Growing Medical Tourism Driving Market Expansion in India”
Obesity management is an evolving area of focus, which has been witnessing an upsurge in demand, due to the increasing medical tourism in India.
Rising medical tourism for weight loss and obesity management in India provides immense opportunities for the weight loss and obesity management market players to launch products that would further contribute to driving the growth of the global weight loss and obesity management market.
Category-Wise Insights
Which Product Type is Gaining Immense Popularity in Weight Loss and Obesity Management?
“Increasing Number of Bariatric Surgeries Driving Demand for Bariatric Stapling Devices”
After eating, exercise, and other medically advised weight loss programs failed, bariatric procedures/weight loss surgeries were once thought to be the last option for weight loss. Bariatric stapling devices type USD share will increase significantly in the global weight loss and obesity management market.
Many bariatric stapling devices are being used for bariatric surgeries, which help in controlling hunger by electrically stimulating the nerves that control our hunger signals. Bariatric operations have become less painful for patients as a result of recent innovations.
As a result, the medical profession is increasingly accepting these surgeries as a viable and long-lasting alternative to traditional weight-loss methods. Hence bariatric stapling devices are in more demand.
Which Distribution Channel Leads Revenue Generation of Weight Loss and Obesity Management?
“Online Sales Most Preferred Because of Easy Availability of Products”
By distribution channel, the online sales channel USD is expected to gain the largest share over the coming years. The rate of internet penetration has risen dramatically during the last several years around the world. According to reports, over 54% of the world's population has internet connections.
As a result, the weight reduction and weight management business have seen an increase in the use of digital services. Obesity has become a major concern worldwide as meal replacements and exercise are inadequate for weight loss and obesity management.
Sometimes targeted treatments must be combined with additional pharmacologic therapy drugs. The easy availability of drugs, high-quality food, and dietary supplements are driving the demand for online sales channels.
COVID-19 Impact On Industry
The COVID-19 pandemic has had a severe impact on the market. Weight loss and obesity management products suffered a drop in sales during the pandemic, according to the medical device industry. Because of the growing COVID-19 infection, hospitals have postponed or rescheduled non-essential surgical and non-invasive procedures.
Demand for fitness equipment has surged as individuals have become more health-conscious. Technological platforms and solutions are being implemented to handle rising consumer demand, change consumer behavior, and improve supply chains and raw material sourcing. The market is stabilizing and appears to have the most potential for growth over the coming years.
Competitive Landscape
Key weight loss and obesity management equipment manufacturers are taking a few to hold a competitive edge in the market. Companies are focusing on launching advanced surgical equipment and training equipment, which is propelling the global weight loss and obesity treatment market forward.
For instance,
In May 2021, according to conclusions of a Phase IIIa research published, Novo Nordisk's weight-loss medicine semaglutide can increase physical function and well-being in obese persons.
Weight Loss And Obesity Management Industry Report Scope
Attributes
Details
Forecast Period
2022 to 2028
Historical Data Available for
2013 to 2021
Market Analysis
Value in US$ Million
Key Regions Covered
North America
Latin America
Europe
East Asia
South Asia & Pacific
Middle East & Africa (MEA)
Key Countries Covered
USA
Canada
Mexico
Brazil
Mexico
Argentina
Germany
Italy
France
UK
Nordic
Spain
Japan
China
India
Malaysia
Thailand
Australia
GCC Countries
South Africa
Turkey
Key Market Segments Covered
Product Type
Distribution Channel
Region
Key Companies Profiled
GlaxoSmithKline plc.
Allergan Plc
Johnson & Johnson Services, Inc.
Vivus Inc.
Eisai Co., Ltd.
ReShape Lifesciences, Inc.
Aspire Bariatrics
Allurion Technologies Inc.
Cheplapharm Arzneimittel GmbH
Beijing Noble Laser Technology Co., Ltd.
Pricing
Available upon Request
Key Segments Of Weight Loss And Obesity Management Industry Survey
Weight Loss and Obesity Management Market by Product Type:
Weight Loss and Obesity Management Devices
Liposuction Devices
Laser-assisted Liposuction Devices
Radio Frequency-assisted Liposuction Devices
Ultrasound-assisted Liposuction Devices
Bariatric Stapling Devices
Gastric Bands
Gastric Balloon Systems
Gastric Emptying Systems
Gastric Electrical Stimulation Systems
Weight Loss and Obesity Management Drugs
GLP-1 Receptor Agonists
Lipase Inhibitors
Serotonin Receptor Agonists
Combination Drugs
Others
Weight Loss and Obesity Management Market by Distribution Channel:
Institutional Sales
Hospitals
Weight Loss Clinics
Ambulatory Surgery Centers
Retail Sales
Retail Pharmacies
Drug Stores
Online Sales
Weight Loss and Obesity Management Market by Region:
North America Weight Loss and Obesity Management Market
Latin America Weight Loss and Obesity Management Market
Europe Weight Loss and Obesity Management Market
East Asia Weight Loss and Obesity Management Market
South Asia & Pacific Weight Loss and Obesity Management Market
Middle East & Africa (MEA) Weight Loss and Obesity Management Market
Frequently Asked Questions
North America accounts for 43% share of the global weight loss and obesity management market.
GlaxoSmithKline plc., Allergan Plc, Johnson & Johnson Services, Inc., Vivus Inc., and Eisai Co., Ltd. are top providers of weight loss and obesity management systems.
The global market for weight loss and obesity management is expected to reach a valuation of US$ 3.68 Bn in 2022.
Increasing obese population, rising number of bariatric surgeries, and growing adoption of online weight loss and weight management programs are driving market growth.
The global weight loss and obesity management market is expected to rise at a CAGR of 5.2% from 2022 to 2028 to reach US$ 4.99 Bn by 2028.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Key Success Factors
3.1. Regulatory Scenario
3.2. Pipeline Assessment
3.3. Potential of Anti-Obesity Drugs In The Market
3.4. Key Market Entry Strategies
3.5. White Space Analysis
4. Global Market - Pricing Analysis
4.1. Regional Pricing Analysis By Product Type
4.2. Pricing Break-up
4.2.1. Manufacturer Level Pricing
4.2.2. Distributor Level Pricing
4.3. Global Average Pricing Analysis Benchmark
5. Global Market Demand (in Value or Size in US$ Mn) Analysis 2013-2021 and Forecast, 2022-2028
5.1. Historical Market Value (US$ Mn) Analysis, 2013-2021
5.2. Current and Future Market Value (US$ Mn) Projections, 2022-2028
5.2.1. Y-o-Y Growth Trend Analysis
5.2.2. Absolute $ Opportunity Analysis
6. Market Background
6.1. Macro-Economic Factors
6.1.1. Increasing Investments Towards Obesity Treatment
6.1.2. Global Increase In Healthcare Spending
6.1.3. Shift Towards A Value-Based Healthcare Model
6.2. Forecast Factors - Relevance & Impact
6.2.1. New/Approved Product Launches
6.2.2. Treatment Rate
6.2.3. Prevalence of Obesity
6.2.4. Technological Advancements
6.2.5. Acceptance of Drugs by Prescribers
6.2.6. Reimbursement Policies
6.2.7. Product Penetration Rate Across End Users
6.2.8. Adoption Rate among Patients
6.2.9. Product Penetration across Regions
6.2.10. Penetration of Product in Different Distribution Channel
6.3. Value Chain
6.4. Market Dynamics
6.4.1. Drivers
6.4.2. Restraints
6.4.3. Opportunity Analysis
7. Global Market Analysis 2013-2021 and Forecast 2022-2028, by Product Type
7.1. Introduction / Key Findings
7.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2013 - 2021
7.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Product Type, 2022 - 2028
7.3.1. Devices
7.3.1.1. Liposuction Device
7.3.1.1.1. Laser Assisted Liposuction Devices
7.3.1.1.2. Radio Frequency Assisted Liposuction Devices
7.3.1.1.3. Ultrasound Assisted Liposuction Devices
7.3.1.2. Bariatric Stapling Devices
7.3.1.3. Gastric Band
7.3.1.4. Gastric Balloon Systems
7.3.1.5. Gastric Emptying Systems
7.3.1.6. Gastric Electrical Stimulation Systems
7.3.2. Drugs
7.3.2.1. GLP-1 receptor agonists
7.3.2.2. Lipase Inhibitors
7.3.2.3. Serotonin Receptor Agonist
7.3.2.4. Combination Drug
7.3.2.5. Others
7.4. Market Attractiveness Analysis By Product Type
8. Global Market Analysis 2013-2021 and Forecast 2022-2028, by Distribution Sales
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Distribution Sales, 2013 - 2021
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Sales, 2022 - 2028
8.3.1. Institutional Sales
8.3.1.1. Hospitals
8.3.1.2. Weightloss Clinics
8.3.1.3. Ambulatory Surgery Centers
8.3.2. Retail Sales
8.3.2.1. Retail Pharmacies
8.3.2.2. Drug Stores
8.3.2.3. Online Sales
8.4. Market Attractiveness Analysis By Distribution Sales
9. Global Market Analysis 2013-2021 and Forecast 2022-2028, by Region
9.1. Introduction
9.2. Historical Market Size (US$ Mn) Analysis By Region, 2013 - 2021
9.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2022 - 2028
9.3.1. North America
9.3.2. Latin America
9.3.3. Europe
9.3.4. Middle East and Africa (MEA)
9.3.5. East Asia
9.3.6. South Asia
9.3.7. Oceania
9.4. Market Attractiveness Analysis By Region
10. North America Market Analysis 2013-2021 and Forecast 2022-2028
10.1. Introduction
10.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2013 - 2021
10.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2028
10.3.1. By Country
10.3.1.1. U.S.
10.3.1.2. Canada
10.3.2. By Product Type
10.3.3. By Distribution Sales
10.4. Market Attractiveness Analysis
10.4.1. By Country
10.4.2. By Product Type
10.4.3. By Distribution Sales
10.5. Drivers and Restraints - Impact Analysis
11. Latin America Market Analysis 2013-2021 and Forecast 2022-2028
11.1. Introduction
11.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2013 - 2021
11.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2028
11.3.1. By Country
11.3.1.1. Brazil
11.3.1.2. Mexico
11.3.1.3. Rest of Latin America
11.3.2. By Product Type
11.3.3. By Distribution Sales
11.4. Market Attractiveness Analysis
11.4.1. By Country
11.4.2. By Product Type
11.4.3. By Distribution Sales
11.5. Drivers and Restraints - Impact Analysis
12. Europe Market Analysis 2013-2021 and Forecast 2022-2028
12.1. Introduction
12.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2013 - 2021
12.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2028
12.3.1. By Country
12.3.1.1. Germany
12.3.1.2. Italy
12.3.1.3. France
12.3.1.4. U.K.
12.3.1.5. Spain
12.3.1.6. Russia
12.3.1.7. Rest of Europe
12.3.2. By Product Type
12.3.3. By Distribution Sales
12.4. Market Attractiveness Analysis
12.4.1. By Country
12.4.2. By Product Type
12.4.3. By Distribution Sales
12.5. Drivers and Restraints - Impact Analysis
13. South Asia Market Analysis 2013-2021 and Forecast 2022-2028
13.1. Introduction
13.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2013 - 2021
13.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2028
13.3.1. By Country
13.3.1.1. India
13.3.1.2. Thailand
13.3.1.3. Indonesia
13.3.1.4. Malaysia
13.3.1.5. Rest of South Asia
13.3.2. By Product Type
13.3.3. By Distribution Sales
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Product Type
13.4.3. By Distribution Sales
13.5. Drivers and Restraints - Impact Analysis
14. East Asia Market Analysis 2013-2021 and Forecast 2022-2028
14.1. Introduction
14.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2013 - 2021
14.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2028
14.3.1. By Country
14.3.1.1. China
14.3.1.2. Japan
14.3.1.3. South Korea
14.3.2. By Product Type
14.3.3. By Distribution Sales
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Product Type
14.4.3. By Distribution Sales
14.5. Drivers and Restraints - Impact Analysis
15. Oceania Market Analysis 2013-2021 and Forecast 2022-2028
15.1. Introduction
15.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2013 - 2021
15.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2028
15.3.1. By Country
15.3.1.1. Australia
15.3.1.2. New Zealand
15.3.2. By Product Type
15.3.3. By Distribution Sales
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Product Type
15.4.3. By Distribution Sales
15.5. Drivers and Restraints - Impact Analysis
16. Middle East and Africa Market Analysis 2013-2021 and Forecast 2022-2028
16.1. Introduction
16.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2013 - 2021
16.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2028
16.3.1. By Country
16.3.1.1. GCC Countries
16.3.1.2. Turkey
16.3.1.3. South Africa
16.3.1.4. Rest of Middle East and Africa
16.3.2. By Product Type
16.3.3. By Distribution Sales
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Product Type
16.4.3. By Distribution Sales
16.5. Drivers and Restraints - Impact Analysis
17. Emerging Countries Market Analysis 2013-2021 and Forecast 2022-2028
17.1. Introduction
17.1.1. Market Value Proportion Analysis, By Key Countries
17.1.2. Global Vs. Country Growth Comparison
17.2. China Market Analysis
17.2.1. Introduction
17.2.2. Market Value Proportion Analysis by Market Taxonomy
17.2.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy
17.2.3.1. By Product Type
17.2.3.2. By Distribution Sales
17.2.4. China Market - Competition Landscape
17.3. India Market Analysis
17.3.1. Introduction
17.3.2. Market Value Proportion Analysis by Market Taxonomy
17.3.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy
17.3.3.1. By Product Type
17.3.3.2. By Distribution Sales
17.3.4. India Market - Competition Landscape
17.4. Brazil Market Analysis
17.4.1. Introduction
17.4.2. Market Value Proportion Analysis by Market Taxonomy
17.4.3. Market and Value (US$ Mn) Analysis and Forecast by Market Taxonomy
17.4.3.1. By Product Type
17.4.3.2. By Distribution Sales
17.4.4. Mexico Market - Competition Landscape
18. Market Structure Analysis
18.1. Brand Share Analysis of Top Players
19. Competition Analysis
19.1. Competition Dashboard
19.2. Competition Benchmarking
19.3. Competition Deep Dive
19.3.1. Novo Nordisk A/S
19.3.1.1. Overview
19.3.1.2. Product Portfolio
19.3.1.3. Profitability by Market Segments (Product/Channel/Region)
19.3.1.4. Sales Footprint
19.3.1.5. Strategy Overview
19.3.1.5.1. Marketing Strategy
19.3.1.5.2. Product Strategy
19.3.1.5.3. Channel Strategy
19.3.2. GlaxoSmithKline plc.
19.3.3. F. Hoffmann-La Roche AG
19.3.4. Allergan Plc
19.3.5. Johnson & Johnson Services, Inc
19.3.6. Medtronic plc.
19.3.7. Vivus Inc.
19.3.8. Eisai Co., Ltd.
19.3.9. ReShape Lifesciences, Inc.
19.3.10. Obalon Therapeutics
19.3.11. Aspire Bariatrics
19.3.12. Allurion Technologies Inc.
19.3.13. Nalpropion Pharmaceuticals, Inc.
19.3.14. Cheplapharm Arzneimittel GmbH
19.3.15. Beijing Noble Laser Technology Co., Ltd
20. Assumptions and Acronyms Used21. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 01: Pipeline Assessment of Drugs for Obesity (1/13)
Table 02: Pipeline Assessment of Drugs for Obesity (2/13)
Table 03: Pipeline Assessment of Drugs for Obesity (3/13)
Table 04: Pipeline Assessment of Drugs for Obesity (4/13)
Table 05: Pipeline Assessment of Drugs for Obesity (5/13)
Table 06: Pipeline Assessment of Drugs for Obesity (6/13)
Table 07: Pipeline Assessment of Drugs for Obesity (7/13)
Table 08: Pipeline Assessment of Drugs for Obesity (8/13)
Table 09: Pipeline Assessment of Drugs for Obesity (9/13)
Table 10: Pipeline Assessment of Drugs for Obesity (10/13)
Table 11: Pipeline Assessment of Drugs for Obesity (11/13)
Table 12: Pipeline Assessment of Drugs for Obesity (12/13)
Table 13: Pipeline Assessment of Drugs for Obesity (13/13)
Table 14: Price (US$) Comparison of Medical Procedures for Weight Loss in Different Countries, 2022
Table 15: Global Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product Type (1/2)
Table 16: Global Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product Type (2/2)
Table 17: Global Market Volume (Units) Analysis 2013-2021 and Forecast 2022-2028, By Product Type
Table 18: Global Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Distribution Sales
Table 19: Global Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Region
Table 20: North America Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Country
Table 21: North America Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product Type (1/2)
Table 22: North America Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product Type (2/2)
Table 23: North America Market Volume (Units) Analysis 2013-2021 and Forecast 2022-2028, By Product
Table 24: North America Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Distribution Sales
Table 25: Latin America Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Country
Table 26: Latin America Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product Type (1/2)
Table 27: Latin America Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product Type (2/2)
Table 28: Latin America Market Volume (Units) Analysis 2013-2021 and Forecast 2022-2028, By Product Type
Table 29: Latin America Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Distribution Sales
Table 30: Europe Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Country
Table 31: Europe Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product Type (1/2)
Table 32: Europe Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product Type (2/2)
Table 33: Europe Market Volume (Units) Analysis 2013-2021 and Forecast 2022-2028, By Product Type
Table 34: Europe Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Distribution Sales
Table 35: South Asia Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Country
Table 36: South Asia Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product Type (1/2)
Table 37: South Asia Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product Type (2/2)
Table 38: South Asia Market Volume (Units) Analysis 2013-2021 and Forecast 2022-2028, By Product Type
Table 39: South Asia Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Distribution Sales
Table 40: East Asia Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Country
Table 41: East Asia Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product Type (1/2)
Table 42: East Asia Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product Type (2/2)
Table 43: East Asia Market Volume (Units) Analysis 2013-2021 and Forecast 2022-2028, By Product Type
Table 44: East Asia Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Distribution Sales
Table 45: Oceania Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Country
Table 46: Oceania Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product Type (1/2)
Table 47: Oceania Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product Type (2/2)
Table 48: Oceania Market Volume (Units) Analysis 2013-2021 and Forecast 2022-2028, By Product Type
Table 49: Oceania Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Distribution Sales
Table 50: Middle East & Africa Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Country
Table 51: Middle East & Africa Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product Type (1/2)
Table 52: Middle East & Africa Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product Type (2/2)
Table 53: Middle East & Africa Market Volume (Units) Analysis 2013-2021 and Forecast 2022-2028, By Product Type
Table 54: Middle East & Africa Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Distribution Sales
Table 55: China Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product Type (1/2)
Table 56: China Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product Type (2/2)
Table 57: China Market Volume (Units) Analysis 2013-2021 and Forecast 2022-2028, By Product Type
Table 58: China Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Distribution Sales
Table 59: India Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product Type (1/2)
Table 60: India Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product Type (2/2)
Table 61: India Market Volume (Units) Analysis 2013-2021 and Forecast 2022-2028, By Product Type
Table 62: India Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Distribution Sales
Table 63: Brazil Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product Type (1/2)
Table 64: Brazil Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product Type (2/2)
Table 65: Brazil Market Volume (Units) Analysis 2013-2021 and Forecast 2022-2028, By Product Type
Table 66: Brazil Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Distribution Sales
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 01: Market size (US$ Mn) 2022E, 2022F, & 2028F
Figure 02: Market Value Share by Product Type (2022E)
Figure 03: Obesity Drug Development Pipeline by Phase
Figure 04: Per-Capita Pharmaceutical Spending and Absolute Incidence of Obesity
Figure 05: Percent of Patients Remaining on Therapy Over 1 Year
Figure 06: Global Market Size and Y-o-Y, 2013 - 2021
Figure 07: Global Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 08: Global Market Absolute $ Opportunity, 2021–2028
Figure 09: Increasing Prevalence of Obesity in Adults, by Region, 1990-2014
Figure 10: Increasing number of Bariatric Surgery Numbers, 2011-2021
Figure 11: Global Market Share Analysis (%) By Product Type, 2022 & 2028
Figure 12: Global Market Y-o-Y Growth (%) By Product Type, 2022–2028
Figure 13: Global Market Attractiveness Analysis, By Product Type
Figure 14: Global Market Share Analysis (%) By Distribution Sales, 2022 & 2028
Figure 15: Global Market Y-o-Y Growth (%) By Distribution Sales, 2022–2028
Figure 16: Global Market Attractiveness Analysis, By Distribution Sales
Figure 17: Global Market Share Analysis (%) By Region, 2022 & 2028
Figure 18: Global Market Y-o-Y Growth (%) By Region, 2022–2028
Figure 19: Global Market Attractiveness Analysis, By Region
Figure 20: North America Market Value Share, by Country (2022)
Figure 21: North America Market Value Share, by Product Type (2022)
Figure 22: North America Market Value Share, by Distribution Sales (2022)
Figure 23: North America Market Size (US$ Mn) Analysis, 2013-2021
Figure 24: North America Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2022-2028
Figure 25: North America Market Y-o-Y growth (%) Comparison, By Country, 2022-2028
Figure 26: North America Market Size (US$ Mn) Analysis, 2013-2021, by Devices
Figure 27: North America Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028, by Devices
Figure 28: North America Market Size (US$ Mn) Analysis, 2013-2021, by Drugs
Figure 29: North America Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028, by Drugs
Figure 30: North America Market Attractiveness Analysis, By Country
Figure 31: North America Market Attractiveness Analysis, By Product Type
Figure 32: North America Market Attractiveness Analysis, By Distribution Sales
Figure 33: Latin America Market Value Share, by Country (2022)
Figure 34: Latin America Market Value Share, by Product Type (2022)
Figure 35: Latin America Market Value Share, by Distribution Sales (2022)
Figure 36: Latin America Market Size (US$ Mn) Analysis, 2013-2021
Figure 37: Latin America Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2022-2028
Figure 38: Latin America Market Y-o-Y growth (%) Comparison, By Country, 2022-2028
Figure 39: Latin America Market Size (US$ Mn) Analysis, 2013-2021, by Devices
Figure 40: Latin America Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028, by Devices
Figure 41: Latin America Market Size (US$ Mn) Analysis, 2013-2021, by Drugs
Figure 42: Latin America Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028, by Drugs
Figure 43: Latin America Market Attractiveness Analysis, By Country
Figure 44: Latin America Market Attractiveness Analysis, By Product Type
Figure 45: Latin America Market Attractiveness Analysis, By Distribution Sales
Figure 46: Europe Market Value Share, by Country (2022)
Figure 47: Europe Market Value Share, by Product Type (2022)
Figure 48: Europe Market Value Share, by Distribution Sales (2022)
Figure 49: Europe Market Size (US$ Mn) Analysis, 2013-2021
Figure 50: Europe Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2022-2028
Figure 51: Europe Market Y-o-Y growth (%) Comparison, By Country, 2022-2028
Figure 52: Europe Market Size (US$ Mn) Analysis, 2013-2021, by Devices
Figure 53: Europe Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028, by Devices
Figure 54: Europe Market Size (US$ Mn) Analysis, 2013-2021, by Drugs
Figure 55: Europe Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028, by Drugs
Figure 56: Europe Market Attractiveness Analysis, By Country
Figure 57: Europe Market Attractiveness Analysis, By Product Type
Figure 58: Europe Market Attractiveness Analysis, By Distribution Sales
Figure 59: South Asia Market Value Share, by Country (2022)
Figure 60: South Asia Market Value Share, by Product Type (2022)
Figure 61: South Asia Market Value Share, by Distribution Sales (2022)
Figure 62: South Asia Market Size (US$ Mn) Analysis, 2013-2021
Figure 63: South Asia Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2022-2028
Figure 64: South Asia Market Y-o-Y growth (%) Comparison, By Country, 2022-2028
Figure 65: South Asia Market Size (US$ Mn) Analysis, 2013-2021, by Devices
Figure 66: South Asia Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028, by Devices
Figure 67: South Asia Market Size (US$ Mn) Analysis, 2013-2021, by Drugs
Figure 68: South Asia Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028, by Drugs
Figure 69: South Asia Market Attractiveness Analysis, By Country
Figure 70: South Asia Market Attractiveness Analysis, By Product Type
Figure 71: South Asia Market Attractiveness Analysis, By Distribution Sales
Figure 72: East Asia Market Value Share, by Country (2022)
Figure 73: East Asia Market Value Share, by Product Type (2022)
Figure 74: East Asia Market Value Share, by Distribution Sales (2022)
Figure 75: East Asia Market Size (US$ Mn) Analysis, 2013-2021
Figure 76: East Asia Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2022-2028
Figure 77: East Asia Market Y-o-Y growth (%) Comparison, By Country, 2022-2028
Figure 78: East Asia Market Size (US$ Mn) Analysis, 2013-2021, by Devices
Figure 79: East Asia Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028, by Devices
Figure 80: East Asia Market Size (US$ Mn) Analysis, 2013-2021, by Drugs
Figure 81: East Asia Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028, by Drugs
Figure 82: East Asia Market Attractiveness Analysis, By Country
Figure 83: East Asia Market Attractiveness Analysis, By Product Type
Figure 84: East Asia Market Attractiveness Analysis, By Distribution Sales
Figure 85: Oceania Market Value Share, by Country (2022)
Figure 86: Oceania Market Value Share, by Product Type (2022)
Figure 87: Oceania Market Value Share, by Distribution Sales (2022)
Figure 88: Oceania Market Size (US$ Mn) Analysis, 2013-2021
Figure 89: Oceania Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2022-2028
Figure 90: Oceania Market Y-o-Y growth (%) Comparison, By Country, 2022-2028
Figure 91: Oceania Market Size (US$ Mn) Analysis, 2013-2021, by Devices
Figure 92: Oceania Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028, by Devices
Figure 93: Oceania Market Size (US$ Mn) Analysis, 2013-2021, by Drugs
Figure 94: Oceania Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028, by Drugs
Figure 95: Oceania Market Attractiveness Analysis, By Country
Figure 96: Oceania Market Attractiveness Analysis, By Product Type
Figure 97: Oceania Market Attractiveness Analysis, By Distribution Sales
Figure 98: Middle East & Africa Market Value Share, by Country (2022)
Figure 99: Middle East & Africa Market Value Share, by Product Type (2022)
Figure 100: Middle East & Africa Market Value Share, by Distribution Sales (2022)
Figure 101: Middle East & Africa Market Size (US$ Mn) Analysis, 2013-2021
Figure 102: Middle East & Africa Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2022-2028
Figure 103: Middle East & Africa Market Y-o-Y growth (%) Comparison, By Country, 2022-2028
Figure 104: Middle East & Africa Market Size (US$ Mn) Analysis, 2013-2021, by Devices
Figure 105: Middle East & Africa Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028, by Devices
Figure 106: Middle East & Africa Market Size (US$ Mn) Analysis, 2013-2021, by Drugs
Figure 107: Middle East & Africa Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028, by Drugs
Figure 108: Middle East & Africa Market Attractiveness Analysis, By Country
Figure 109: Middle East & Africa Market Attractiveness Analysis, By Product Type
Figure 110: Middle East & Africa Market Attractiveness Analysis, By Distribution Sales
Figure 111: Global Market Value Proportion Analysis, By Emerging Countries, 2022
Figure 112: Market, Global Vs. Country Growth Y-o-Y (%) Comparison, 2022-2028
Figure 113: China Market Value Analysis (US$ Mn), 2013-2021
Figure 114: China Market Value Forecast (US$ Mn), 2022-2028
Figure 115: India Market Value Analysis (US$ Mn), 2013-2021
Figure 116: India Market Value Forecast (US$ Mn), 2022-2028
Figure 117: Brazil Market Value Analysis (US$ Mn), 2013-2021
Figure 118: Brazil Market Value Forecast (US$ Mn), 2022-2028
Figure 119: Global Market Brand Share (%) Analysis
